ArticleCancer immunology, immunotherapy : CII2009

CD4+ T cell responses to HLA-DP5-restricted wild-type sequence p53 peptides in patients with head and neck cancer.

Kazuaki Chikamatsu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.